Literature DB >> 15346285

Two-dimensional parallel acquisition technique in 3D MR colonography.

G Steidle1, J Schäfer, H P Schlemmer, C D Claussen, F Schick.   

Abstract

PURPOSE: In-vitro and in-vivo examinations to investigate the influence of one (1D)- and two-dimensional (2D) parallel acquisition techniques (PAT) on contrast-to-noise ratio (CNR) and image quality for bright-lumen 3D MR colonography.
MATERIALS AND METHODS: In-vitro measurements were performed on a 1.5 T whole-body MR scanner (MAGNETOM AVANTO(R), Siemens AG, Erlangen) with a standard spoiled 3D gradient-echo (3D GRE) sequence and a volume interpolated 3D GRE (VIBE) sequence using a home-built colon phantom. The relative CNR was determined and image quality evaluated for different acceleration factors (PAT factors). A bright-lumen 3D MR colonography with PAT factors 2, 3, 4 and 6 was performed on a 39-year-old volunteer. The 3D data sets were compared with regard to image quality.
RESULTS: The mean relative CNR values for the in-vitro measurements were 1, 0.81, 0.73, 0.52 and 0.4 (3D GRE) and 1, 0.8, 0.65, 0.45 and 0.3 (VIBE) for the PAT factors 1, 2, 3, 4 and 6, respectively. Residual aliasing artifacts not affecting image quality in a distinct manner were visible for 2D PAT, especially for the VIBE sequence. Increasing the PAT factor up to 6 and decreasing the acquisition time down to 10 seconds for the bright-lumen 3D MR colonography could achieve adequate image quality with significantly reduced image artifacts caused by peristalsis and pulsations. DISCUSSION: Even for high PAT factors up to 6, 2D PAT only leads to a moderate CNR loss. For a 3D MR colonography, distinct shorter acquisition times can be achieved with identical resolution.

Mesh:

Year:  2004        PMID: 15346285     DOI: 10.1055/s-2004-813277

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  3 in total

Review 1.  Total-body MR-imaging in oncology.

Authors:  Juergen F Schaefer; Heinz-Peter W Schlemmer
Journal:  Eur Radiol       Date:  2006-04-19       Impact factor: 5.315

2.  [Cost considerations for whole-body MRI and PET/CT as part of oncologic staging].

Authors:  C Plathow; M Walz; M P Lichy; P Aschoff; C Pfannenberg; H Bock; S M Eschmann; C D Claussen; H P Schlemmer
Journal:  Radiologe       Date:  2008-04       Impact factor: 0.635

3.  Modification of chest radiography exposure parameters using a neonatal chest phantom.

Authors:  Stefan B Schäfer; Sabine Papst; Martin Fiebich; Claudia Rudolph; Jan de Laffolie; Gabriele A Krombach
Journal:  Pediatr Radiol       Date:  2019-10-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.